Direkt zum Inhalt
Merck
  • Glyburide-induced cholestatic hepatitis and liver failure. Case-report and review of the literature.

Glyburide-induced cholestatic hepatitis and liver failure. Case-report and review of the literature.

The Netherlands journal of medicine (1992-06-01)
J P van Basten, B van Hoek, R Zeijen, R Stockbrügger
ZUSAMMENFASSUNG

As sulphonylurea derivatives are used ubiquitously, the possibility that they may cause liver disease deserves attention. In contrast to the known pattern of reversible parenchymal liver disease due to sulphonylurea derivatives, we describe a fatal case of glyburide-induced cholestatic hepatitis with liver failure.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Glybenclamid, ≥99% (HPLC)
Supelco
Glyburid (Glibenclamid), Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Glyburid, meets USP testing specifications
Glibenclamid für die Peakidentifizierung, European Pharmacopoeia (EP) Reference Standard
Glybenclamid, European Pharmacopoeia (EP) Reference Standard